Some investors asked questions on the investor interaction platform: Dear Secretary: Hello! Is it true that the covid-19 product of xiupu biotechnology, a wholly-owned subsidiary of the company, has been approved by the U.S. fdaeua? thank you!!!
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) (300942. SZ) said on the investor interaction platform on January 17 that the FDA EUA application of xiupu biology, a subsidiary, is currently in active progress and there is still uncertainty.
